---
title: MULTISCREEN™ Non-Radioactive GTP Gi Binding Assay for Drug Discovery
---

| View in browser Follow us on Linkedin to receive more updates! Assess Target Engagement and Target Pharmacology in MULTISCREEN™ Non-Radioactive GTP Gi Binding Assays!  ○ 560+ functionally-validated GPCR stable cell lines for VERSATILITY   ○ MULTISCREEN™ membrane preparation for HIGH QUALITY   ○ Rigorous assay protocols and processes for ROBUSTNESS AND REPRODUCIBILITY   ○ An experienced team for CUSTOMIZATION Explore More! Optimized to meet any HTS and lead optimization needs MULTISCREEN™  Non-Radioactive MOR GTP Gi Binding Assay Example Learn More What do our customers say? “Over the past two years I worked with Multispan on the discovery and optimization of partial agonist ligands for a Gi/o coupled GPCR. Multispan supported the in vitro effort that enabled the compound optimization by implementing and running radiolabel binding assays to evaluate the affinity of ligands, cAMP assays in agonist and antagonist modes to evaluate functional activity, GTPgS assays to accurately measure the efficacy of ligands on the receptor, ARRB-2 assays to evaluate the arresting signaling pathway and receptor internalization assays to evaluate functional activity. The work performed by Multispan was professional with good reproducibility from week-to-week, quick turnaround and cost effective. The Multispan team is easy to work with and when the assays deviated from the norm they were quick to repeat the data and address problems."   Julio Medina, Ph.D. R2M Pharma Inc. C.E.O.   info@multispaninc.com   www.multispaninc.com Multispan, Inc., 26219 Eden Landing Road, Hayward, CA 94545, United States, 510-887-0817 Unsubscribe Manage preferences |
| --- |